Physician profile
Michael Craig Scott
NPI 1760471247
$1,931.27
in general payments reported to CMS, 2019-2025
22 companies · $15.04 in 2025
The $15.04 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $270 · 2021: $404 · 2022: $337 · 2023: $190 · 2024: $100 · 2025: $15.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $815.92 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Therapeuticsmd, INC. | $315.86 | 2019-2021 | |
| Millicent US INC | $152.30 | 2020-2025 | Intrarosa |
| Astellas Pharma US INC | $125.08 | 2022-2024 | Veozah |
| Myovant Sciences INC. | $111.68 | 2021-2022 | |
| Sumitomo Pharma America, INC. | $66.06 | 2023-2024 | Myfembree |
| Duchesnay USA Incorporated | $35.31 | 2019 | |
| Azurity Pharmaceuticals, INC. | $32.36 | 2023 | Adthyza |
| Bayer Healthcare Pharmaceuticals INC. | $30.89 | 2020-2021 | |
| Minerva Surgical, INC | $28.38 | 2019-2021 | |
| Allergan, INC. | $24.91 | 2019-2020 | |
| Pfizer INC. | $22.98 | 2024 | |
| Evofem Biosciences, INC. | $22.83 | 2020-2021 | |
| Shield Therapeutics INC | $22.16 | 2023 | Accrufer |
| Mayne Pharma Commercial LLC | $19.48 | 2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.77 | 2023 | Aptima |
| Agile Therapeutics, INC. | $18.70 | 2021 | |
| Baxter Healthcare | $18.47 | 2021 | |
| Covidien Lp | $18.07 | 2019 | |
| Avion Pharmaceuticals | $15.79 | 2021 | |
| Virtus Pharmaceuticals LLC | $11.99 | 2021 | |
| Aspira Women'S Health INC | $3.28 | 2024 | Ova1 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.